UK markets close in 4 hours 3 minutes

IceCure Medical Ltd (ICCM)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
1.04000.0000 (0.00%)
At close: 04:00PM EDT
1.0694 +0.03 (+2.83%)
After hours: 07:45PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 49.86M
Enterprise value 39.44M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)14.56
Price/book (mrq)3.87
Enterprise value/revenue 11.35
Enterprise value/EBITDA -2.63

Trading information

Stock price history

Beta (5Y monthly) 3.00
52-week change 3-1.89%
S&P500 52-week change 326.94%
52-week high 31.5700
52-week low 30.5200
50-day moving average 31.1912
200-day moving average 31.0850

Share statistics

Avg vol (3-month) 3402.35k
Avg vol (10-day) 3249.04k
Shares outstanding 547.94M
Implied shares outstanding 647.94M
Float 818.9M
% held by insiders 159.30%
% held by institutions 10.22%
Shares short (15 May 2024) 4243.24k
Short ratio (15 May 2024) 40.32
Short % of float (15 May 2024) 41.20%
Short % of shares outstanding (15 May 2024) 40.53%
Shares short (prior month 15 Apr 2024) 4299.76k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)-272.11%

Management effectiveness

Return on assets (ttm)-41.78%
Return on equity (ttm)-77.97%

Income statement

Revenue (ttm)3.23M
Revenue per share (ttm)0.07
Quarterly revenue growth (yoy)33.70%
Gross profit (ttm)N/A
EBITDA -15.25M
Net income avi to common (ttm)-14.65M
Diluted EPS (ttm)-0.3200
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)11.06M
Total cash per share (mrq)0.24
Total debt (mrq)599k
Total debt/equity (mrq)4.93%
Current ratio (mrq)3.66
Book value per share (mrq)0.27

Cash flow statement

Operating cash flow (ttm)-12.52M
Levered free cash flow (ttm)-7.75M